Discover myCOPD

Digital Pulmonary Rehabilitation.

my mhealth’s flagship evidence-based digital intervention for Chronic Obstructive Pulmonary Disease.

Find Out More

myCOPD, my mhealth’s proven digital platform with over 100,000 users, now available in the US.

What is myCOPD?

myCOPD is the complete app for patients living with COPD. Online pulmonary rehabilitation classes from the comfort of home.

myCOPD: A powerful self-management tool

Perfect inhaler technique with our easy-to-follow inhaler videos and learn how to manage COPD from world experts and get the very best in COPD care. myCOPD will assist your clinical teams to deliver the very best in patient self-management, with access to expert education, inhaler technique training, mindfulness toolkits and a complete Pulmonary Rehabilitation (PR) course.

Read the research

Digitally Enhanced Pulmonary Rehabilitation (DEPR)

Pulmonary Rehabilitation (PR) is a highly effective therapy for Chronic Obstructive Pulmonary Disease (COPD), improving symptoms, exercise capacity and quality of life.

If PR is given in time, 1-year hospital readmission and mortality rates can be reduced by 50% and 40% respectively.

myCOPD addresses a critical challenge around a lack of access to traditional, in person PR classes:

Currently, only 3% of patients in the US who are eligible
for PR receive it.

Low resources, staffing and infrastructure and insurance reimbursement has led to only 1 traditional PR center for every 6,030 individuals with COPD.

Benefits of using myCOPD to support a DEPR approach.

Increased capacity

Choice of fully remote (myCOPD only) or hybrid (myCOPD plus traditional PR) means that more patients receive treatment.

Increased revenue

DEPR enables physician billing to CMS codes which cannot be accessed for traditional PR.

Lower readmission costs

COPD is the 3rd leading cause of readmission in the US - an increase in PR capacity results in admission savings of between $7,000-$15,000 per patient.

Better patient engagement

myCOPD’s DEPR programs have >70% PR program completion rates.

For Patients.

myCOPD is the complete app for patients living with COPD. Perfect your inhaler technique with our easy-to-follow inhaler videos and learn how to manage your COPD from world experts. Complete online pulmonary rehabilitation classes from the comfort of your home and get the very best in COPD care.

Medication Management

Record and track when you take your medication and view in the medication diary.

Pulmonary Rehab

No more waiting lists and no more travel. A complete pulmonary rehabilitation program delivered in your home.

Educational Course

Full online educational course from world experts.

Self-management plan

Know when, and how to take your medication with our online, easy to follow, self-management plan.

Weather & pollution forecast

Receive an accurate forecast daily and understand how the weather and air pollution in your local area can impact on your health.

Inhaler technique videos

We show you how and when to use your medication. 90% of patients are unable to use their inhalers correctly. This section will help you correct all of those errors, instantly.

Trial Evidence.

3 randomised clinical trials and 10 Real World Evaluations.

Real World Evidence:

myCOPD delivers a 100% capacity increase in PR and a higher completion rate relative to a conventional model.

Independent NICE public involvement survey; (8)

82.7% reported myCOPD is easy to use & helped improve understanding of condition & symptoms. 66.1% felt a reduction in number of exacerbations. 74.6% felt confident in managing COPD symptoms after using myCOPD

Randomised Clinical Trial:

‘Non-inferior’ vs. conventional model relying on face-to-face sessions (6 min walk test, symptom scores).

Testimonials & Patient Stories.

Here's just some of the feedback we've received from patients and clinical teams.

“As effective as hospital-based programs.”

Global Strategy for the Diagnosis and Management of COPD (GOLD 2023).

“The tragedy in the US is that [PR] is only available to such a small percentage."

David Mannino, MD, FCCP, FERS Director, Pulmonary Epidemiology University of Kentucky.

“A ‘business in a box’ that drives practice revenue and provides the best possible care for patients that extends lives, and saves lives.”

myCOPD Customer (US Healthcare Provider).

” If pulmonary rehabilitation was a medication, IT WOULD BE A BLOCKBUSTER.”

David Mannino, MD, FCCP, FERS Director, Pulmonary Epidemiology University of Kentucky.

One product, two solutions for optimized COPD management.

myCOPD comes in two forms: myCOPD Essentials , contains the Core Pulmonary Rehabilitation Experience and myCOPD Pro, for full Remote Patient Monitoring.

Who are my mhealth?

my mhealth offers evidence-based digital interventions for Asthma, COPD, Diabetes and Cardiovascular Disease & empowers patients to self-manage their long-term conditions, leading to improvements in clinical outcomes.

Our global user base is over 100,000 and growing. We have clinical trial and real-world data demonstrating improved medication management, increased access to structured education and rehabilitation.

Find out more